SCHEMBL14308570

SCHEMBL14308570

O=COC(=O)NCCc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.55
RAB9A P51151 4/20 0.55
TAAR1 Q96RJ0 3/20 0.55
GAA P10253 1/20 0.55
CA12 O43570 2/20 0.54
CA2 P00918 2/20 0.54
CA9 Q16790 2/20 0.54
ALDH1A1 P00352 3/20 0.54
EPHX1 P07099 1/20 0.53
SMN1; SMN2 Q16637 4/20 0.53
HPGD P15428 1/20 0.53
MMP1 P03956 2/20 0.51
MMP2 P08253 2/20 0.51
PLAAT5 Q96KN8 2/20 0.51
PLAAT4 Q9UL19 2/20 0.51
CA1 P00915 1/20 0.51
MMP3 P08254 1/20 0.51
POLB P06746 1/20 0.51
MMP9 P14780 1/20 0.51
RECQL P46063 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21121950 0.82 ALDH1A1 (0.51) GAAALDH1A1EPHX1SMN1; SMN2HPGD
SCHEMBL2095490 0.80 TAAR1 (0.69) NPC1RAB9ATAAR1GAACA12
SCHEMBL2095487 0.79 NPC1 (0.58) NPC1RAB9ATAAR1GAACA12
SCHEMBL22282200 0.79 NPC1 (0.58) NPC1RAB9ATAAR1GAACA12
SCHEMBL28277097 0.79 TAAR1 (0.58) NPC1RAB9ATAAR1GAACA12
SCHEMBL28203595 0.79 NPC1 (0.58) NPC1RAB9ATAAR1GAACA12
SCHEMBL28010694 0.79 NPC1 (0.58) NPC1RAB9ATAAR1GAACA12
SCHEMBL12582415 0.79 HTT (0.54) GAAALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL23120896 0.78 HDAC3 (0.52) NPC1RAB9ATAAR1GAACA12
SCHEMBL19387598 0.77 NPC1 (0.56) NPC1RAB9ATAAR1GAACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109966240-A The subcutaneously composition and method of fatty local delivery prostaglandin 托普凯恩制药公司 2019-07-05 CN disclosed
CN-106133004-B Catalyst component for olefin polymerization 巴塞尔聚烯烃意大利有限公司 2019-05-07 CN disclosed
CN-105209015-B Compositions and methods for local delivery of prostaglandins to subcutaneous fat 托普凯恩制药公司 2018-11-20 CN disclosed
CN-104718202-B The method for being used to prepare (S) -3- (4- ((4- (morpholinyl methyl) benzyl) oxygroup) -1- oxoisoindolines -2- base) piperidine-2,6-diones and its pharmaceutically acceptable form 细胞基因公司 2018-11-20 CN disclosed
CN-108779460-A Multiplexing using microparticles in dispensing 睿恩达思技术公司 2018-11-09 CN disclosed
CN-104640540-B Enhanced anti-influenza agents coupled with anti-inflammatory activity 中央研究院 2018-10-09 CN disclosed
CN-104010643-B Methods and compositions for reducing body fat and adipocytes 托普凯恩制药公司 2017-03-29 CN disclosed
CN-104024278-B Modificationization polyrotaxane and manufacture method thereof and there is modificationization polyrotaxane and the material that formed 高级软质材料株式会社 2016-10-26 CN disclosed
CN-106029653-A Diaminopyrimidine benzenesulfone derivatives and uses thereof 达纳-法伯癌症研究所股份有限公司 2016-10-12 CN disclosed
EP-1660466-B1 METHOD OF OBTAINING URETHANE-PROTECTED N-CARBOXYANHYDRIDES OF ALPHA AMINO ACIDS ISOCHEM SA (FR) 2008-01-09 EP disclosed